Loading... Please wait...

Our Newsletter

AZD4547 | FGFR1/2/3 inhibitor

  • AZD4547.jpg
  • AZD4547, 400x400px, png
Catalog #:

Product Description

AZD4547 is a pyrazole-based, FGFR1, FGFR2, and FGFR3 inhibitor with IC50 potency of 0.2, 2.5, and 1.8 nM, respectively. Besides modest activity against KDR (IC50, 24 nM), AZD4547 displays high selectivity towards unrelated tyrosine and serine-threonine kinases. [1] In cells, AZD4547 inhibits autophosphorylation of FGFR1, 2, and 3 at IC50 values of 12, 2, and 40 nM, respectively, along with downstream components, MAPK, FRS2, and PLCg in a dose-dependent manner. Antiproliferative effects of AZD4547 were observed predominantly in tumor cell lines with deregulated FGFR expression.

Preclinical studies indicate that AZD4547 does not induce known deleterious effects normally associated and characterized with KDR inhibition.

Technical information:

Chemical Formula:   C26H33N5O3
CAS #:   1035270-39-3
Molecular Weight:   463.57
Purity:   >98%
Appearance:   White
Chemical Name:   N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzamide
Solubility:   Up to 100 mM in DMSO
Synonyms:   AZD-4547, AZD 4547, AZD4547

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


1. Gavine et al., AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family. Cancer Res. 2012, 72, 2045-2056. Pubmed ID: 22369928

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the AZD4547 | FGFR1/2/3 inhibitor to your wish list.

You Recently Viewed...